Al Madhoun Ashraf
Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15400, Kuwait.
World J Diabetes. 2024 Sep 15;15(9):1837-1841. doi: 10.4239/wjd.v15.i9.1837.
In this editorial, we comment on the article by Wu published "MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4". Diabetic kidney disease (DKD) stands as a significant complication occurring from diabetes mellitus, which contributes substantially to the morbidity and mortality rates worldwide. Renal tubular epithelial cell da-mage, often accompanied by inflammatory responses and mesenchymal trans-differentiation, plays a pivotal role in the progression of DKD. Despite extensive research, the intricate molecular mechanisms underlying these processes remain to be determined. Wu remarkable work identifies microRNA-630 (miR-630) as an emerging potential regulator of cell migration, apoptosis, and autophagy, prompting investigation into its association with DKD pathogenesis. This study endeavors to elucidate the impact of miR-630 on TEC injury and the inflammatory response in DKD rats. The role of miR-630 in human DKD will be of interest for future studies.
在这篇社论中，我们对吴发表的“MicroRNA-630通过靶向Toll样受体4减轻糖尿病肾病大鼠的炎症反应”一文进行评论。糖尿病肾病（DKD）是糖尿病的一种重要并发症，在全球范围内对发病率和死亡率有重大影响。肾小管上皮细胞损伤常伴有炎症反应和间充质转分化，在DKD的进展中起关键作用。尽管进行了广泛研究，但这些过程背后复杂的分子机制仍有待确定。吴的出色工作确定了微小RNA-630（miR-630）是细胞迁移、凋亡和自噬的一种新的潜在调节因子，促使人们研究其与DKD发病机制的关联。本研究旨在阐明miR-630对DKD大鼠肾小管上皮细胞损伤和炎症反应的影响。miR-630在人类DKD中的作用将是未来研究的关注点。
